Tumor marker levels, in certain situations, reflect tumor burden in the body and hence can be used in staging, prognostication or prediction of response to therapy.[5] Malignancies where serum tumor markers are included in the staging protocols include testicular germ cell tumors (LDH, AFP, β-hCG)[18] and lymphoma (LDH). The gene discussed is AFP; the disease is neoplasm.